-
Innovation Ranking
Innovation Ranking - Intercept Pharmaceuticals Inc
Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops, and commercializes treatments for non-viral, progressive liver diseases. It develops products using proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor. The company is advancing OCA for the treatment of various other liver diseases. The company harnesses its proprietary bile acid chemistry to develop innovative drugs. It is also advancing INT-787, an FXR...
-
Innovation Ranking
Innovation Ranking - Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes amoxicillin, carprovet, cefpoderm, clavacillin, dexmedesed, enrofloxacin, enroquin, gentaCalm, isoflurane_x000D_ laverdia, marboquim, meloxicam, muricin, ophtHAvet, orthokine , osurnia, rederox, sevoflurane, tzed, vetivex, vetoryl, vetropolycin , zenalpha and zycortal, among others. Its products are used in the therapeutic areas of anesthesia and analgesia, dermatology, pet diets and nutrition, endocrinology, cardiology, exotics and fluid therapy. Dechra manufactures human and veterinary pharmaceutical products for third-party customers....
-
Innovation Ranking
Innovation Ranking - Radius Health Inc
Radius Health Inc (Radius Health), formerly NuVios Inc, is a biopharmaceutical company that develops and markets novel medicines for bone health, and endocrine diseases. The company’s marketed product includes abaloparatide injection, which is indicated for the treatment of postmenopausal women with osteoporosis. Its pipeline encompasses abaloparatide subcutaneous injection (SC) for high risk of fracture in men with osteoporosis; abaloparatide transdermal (TD) patch for postmenopausal women with osteoporosis; elacestrant (RAD1901) for estrogen-receptor (ER)-positive breast cancer; and RAD140 as an oral treatment...
-
Innovation Ranking
Innovation Ranking - Atossa Therapeutics Inc
Atossa Therapeutics Inc (Atossa), formerly Atossa Genetics Inc is a clinical-stage biopharmaceutical company. It develops proprietary therapeutics and delivery methods for breast cancer and other breast conditions. The company’s pipeline pharmaceutical programs include endoxifen, an active metabolite of tamoxifen, used for the treatment of breast density and other breast health conditions. Atossa is developing patented microcatheter technology to deliver fulvestrant as a potential treatment of ductal carcinoma through the nipple to site of early breast cancer. The company also uses...
-
Innovation Ranking
Innovation Ranking - H. Lundbeck AS
H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing, and marketing of pharmaceuticals for the treatment of central nervous system (CNS) diseases including psychiatric and neurological disorders. The company's products are indicated for the treatment of Alzheimer's disease, migraine, depression, Parkinson's disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, depression, anxiety, psychosis, and epilepsy, among others. It operates production facilities in Denmark, Italy, and France, and research centers in the US and Denmark....
-
Innovation Ranking
Innovation Ranking - Orion Corp(G)
Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its...
-
Innovation Ranking
Innovation Ranking - Alkermes Plc
Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development, and commercialization of drugs for the treatment of cancer, neurodegenerative and central nervous system (CNS) diseases. The company’s proprietary products include Aristada and Aristada Initio an extended-release intramuscular injectable suspension for the treatment of schizophrenia; and Vivitrol, a once-monthly, non-addictive, injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence. It grants licenses under its proprietary technologies to enable third...
-
Innovation Ranking
Innovation Ranking - WAVE Life Sciences Ltd.
Wave Life Sciences Ltd (Wave Life Sciences) discovers, develops, and commercializes medicines for genetic diseases. The company's pipeline consists of an mRNA transcript candidate: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for Spinocerebellar ataxia 3; C9orf72 gene candidate for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); USH2A and RhoP23H candidate for retinal diseases; and multiple candidates for other central nervous system (CNS) disorders, and hepatic diseases. The company employs its proprietary chemistry platform to design, optimize and...
-
Innovation Ranking
Innovation Ranking - Cidara Therapeutics Inc
Cidara Therapeutics Inc (Cidara) formerly K2 Therapeutics Inc is a biotechnology company. The company discovers, develops and commercializes novel anti-infectives including immunotherapies. Its pipeline products include rezafungin for the treatment of invasive fungal disease and CD388 for treating influenza. Cidara is investigating RSV AVC program for the treatment of respiratory syncytial virus (RSV), HIV AVC for human immunodeficiency viruses (HIV), CoV AVC for pan coronavirus. The company’s proprietary Cloudbreak, an antiviral platform for the fight against life-threatening infectious diseases that...
-
Innovation Ranking
Innovation Ranking - Synlogic Inc
Synlogic Inc (Synlogic), formerly TMC Therapeutics Inc, is a clinical stage drug development company that develops novel class of living medicines for the treatment of rare and genetic metabolic diseases. The company’s pipeline includes SYNB1618 to treat the Phenylketonuria. It also produces drugs based on its proprietary synthetic biology and microbiome platform for the treatment of diseases, including liver disease, inflammatory and immune disorders, and cancer. The company's synthetic biotics are designed to make therapeutic effects throughout the body from...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.